Parties - National Blood Authority | National Blood Authority

CSL has informed the NBA that the size and technology of CSL’s Broadmeadows plasma fractionation facility means that CSL’s ability to achieve economies of scale and to provide internationally competitive pricing for Australian plasma products is facilitated through a throughput of plasma for fractionation in the order of 500 tonnes per year; ................
................